Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
23.56
+0.21 (0.90%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $767.62 million as of August 21, 2026. Its market cap has increased by 361.07% in one year.
Market Cap
767.62M
Enterprise Value
745.46M
1-Year Change
361.07%
Ranking
Category
Stock Price
$23.56
ChartMarket Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $767.62M, an increase of 1,223.36%. That is a compound annual growth rate of 76.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 767.62M | 296.92% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 793.48M |
| Neurogene | 789.05M |
| CytomX Therapeutics | 777.90M |
| Allogene Therapeutics | 770.44M |
| BridgeBio Oncology Therapeutics | 769.67M |
| Shattuck Labs | 768.78M |
| Gyre Therapeutics | 758.14M |
| Crescent Biopharma | 741.31M |